Skip to main content
大禹生物 logo

大禹生物 — Investor Relations & Filings

Ticker · 920970 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 384 across all filing types
Latest filing 2023-06-26 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920970

About 大禹生物

http://www.sxdysw.cn/

Shanxi Dayu Biological Assistance Co., Ltd. specializes in the research, development, and production of advanced animal nutrition and health solutions. The company focuses on the manufacturing of feed additives, micro-ecological preparations, and biological feed products. Its core portfolio includes probiotics, enzyme preparations, and functional premixes designed to enhance livestock immunity, improve feed conversion rates, and promote sustainable farming practices. By leveraging biotechnology, the firm provides integrated solutions for the aquaculture and animal husbandry sectors, emphasizing scientific innovation and product quality to support the modernization of the agricultural supply chain.

Recent filings

Filing Released Lang Actions
第三届监事会第七次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of the resolution from the Supervisory Board meeting of Shanxi Dayu Bioengineering Co., Ltd. It details the meeting date, attendance, and the approval of the 2022 Supervisory Board Work Report. The document is short (759 characters) and serves as a meeting resolution announcement rather than the full report itself. It does not contain financial statements or detailed analysis, nor does it announce voting results from a shareholder meeting. It is not a full annual report, audit report, or management report. The content fits best with a Regulatory Filing (RNS) as it is a formal regulatory announcement of a board meeting resolution without substantive financial data or report content.
2023-06-26 Chinese
2022 年年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is titled as an "Annual Equity Distribution Implementation Announcement" for the year 2022 by Shanxi Dayu Biological Engineering Co., Ltd. It details the equity distribution plan including stock dividends, cash dividends, tax implications, record dates, and shareholding changes. The document is an announcement of the equity distribution plan approved at the 2023 shareholders' meeting, including specifics on dividend amounts, share issuance, and dates for ex-dividend and record. It does not contain full financial statements or comprehensive financial performance data typical of an Annual Report (10-K) or Interim Report (IR). The document is also not a simple notification of a report publication but a detailed announcement of dividend and share distribution. This fits the definition of a Notice of Dividend Amount (DIV), which includes announcements of dividend amounts, payment dates, and details for shareholders. The document length is 2623 characters, which is consistent with an announcement rather than a full report. Therefore, the correct classification is DIV with high confidence.
2023-06-05 Chinese
股票解除限售公告
Share Issue/Capital Change Classification · 95% confidence The document is a stock-related announcement from Shanxi Dayu Bioengineering Co., Ltd. regarding the lifting of trading restrictions on a specific number of shares (6,922,300 shares) and details about the shareholders involved. It includes information about the stock code, the number of shares released from restriction, the reasons for lifting the restrictions, and the updated share capital structure. There is no financial data, earnings information, or management discussion. The document is an official announcement about changes in share trading status, specifically the lifting of share restrictions, which fits the category of Share Issue/Capital Change (SHA). The document length is short (1555 characters), and it is not a report publication announcement or certification. Therefore, the appropriate classification is SHA with high confidence.
2023-05-30 Chinese
2022 年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a 2022 Annual General Meeting (AGM) resolution announcement for Shanxi Dayu Biological Engineering Co., Ltd. It details the meeting date, attendance, agenda items, and voting results on various proposals including the 2022 board work report, independent directors' report, financial statements, audit report, annual report, profit distribution plan, and other governance matters. The document is a formal announcement of the resolutions passed at the AGM, not the full reports themselves. It includes voting results and legal opinions confirming the validity of the meeting and resolutions. The document length is 6591 characters, which is consistent with a detailed AGM resolution announcement. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-05-18 Chinese
上海市锦天城律师事务所关于山西大禹生物工程股份有限公司 2022 年年度股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2022 Annual General Meeting (AGM) of Shanxi Dayu Biological Engineering Co., Ltd. It details the legality of the AGM's convening, attendance, agenda, and voting results. The document includes extensive information about the AGM procedures and resolutions passed, such as approval of the 2022 financial reports, audit reports, and other shareholder proposals. It does not contain the actual annual report or financial statements but rather confirms the validity and legality of the AGM and its outcomes. This type of document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results of the AGM. The document length (6720 characters) and content confirm it is not a brief announcement but a detailed legal opinion on the AGM proceedings and voting results. Therefore, the correct classification is DVA with high confidence.
2023-05-18 Chinese
投资者关系活动记录表
Earnings Release Classification · 95% confidence The document is an investor relations activity record from Shanxi Dayu Biological Engineering Co., Ltd. It specifically mentions a 2022 annual report earnings explanation meeting held on May 16, 2023, conducted via an online platform. The content includes detailed Q&A about the company's 2022 financial performance, strategies for 2023, reasons for gross margin decline, and share repurchase details. The document is relatively short (1993 characters) and focuses on the discussion and explanation of the annual report results rather than the full annual report itself. It is an earnings explanation meeting, which aligns with the definition of an Earnings Release (ER) as it provides key highlights and management responses about the financial results. It is not the full annual report (10-K), nor a simple announcement of a report (RPA). Therefore, the best classification is Earnings Release (ER). FY 2022
2023-05-16 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.